GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhuzhou Qianjin Pharmaceutical Co Ltd (SHSE:600479) » Definitions » 3-Year Revenue Growth Rate

Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) 3-Year Revenue Growth Rate : 0.10% (As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Zhuzhou Qianjin Pharmaceutical Co 3-Year Revenue Growth Rate?

Zhuzhou Qianjin Pharmaceutical Co's Revenue per Share for the three months ended in Mar. 2025 was ¥2.37.

During the past 12 months, Zhuzhou Qianjin Pharmaceutical Co's average Revenue per Share Growth Rate was -3.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 0.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 1.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 4.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Zhuzhou Qianjin Pharmaceutical Co was 26.30% per year. The lowest was -4.60% per year. And the median was 7.90% per year.


Competitive Comparison of Zhuzhou Qianjin Pharmaceutical Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Zhuzhou Qianjin Pharmaceutical Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhuzhou Qianjin Pharmaceutical Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhuzhou Qianjin Pharmaceutical Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Zhuzhou Qianjin Pharmaceutical Co's 3-Year Revenue Growth Rate falls into.


;
;

Zhuzhou Qianjin Pharmaceutical Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Zhuzhou Qianjin Pharmaceutical Co  (SHSE:600479) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Zhuzhou Qianjin Pharmaceutical Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Zhuzhou Qianjin Pharmaceutical Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhuzhou Qianjin Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 801, Zhuzhou Avenue, Tianyuan District, Hunan Province, Zhuzhou, CHN, 412000
Zhuzhou Qianjin Pharmaceutical Co Ltd is engaged in Chinese medicine, chemical medicine, and health supplies businesses in China. It produces medicines in the form of tablets, granules, and hard capsules. The company's products include Gynecological Qianjin Tablets (Capsules), Blood-Boosting Yimu Pills (Granules), Valsartan Capsules, Enalapril Maleate Tablets, Difenidol Hydrochloride Tablets, Silybin Meglumine Tablets, Entecavir Dispersible Tablets, Gynecological Special Cotton Towel Series, etc.
Executives
Liu Jian Wu senior management
Li Fu Jun Director
Lv Fang Yuan Supervisors
Zhang Shun Li Supervisors
Chen Geng senior management
Zhu Fei Jin Director

Zhuzhou Qianjin Pharmaceutical Co Headlines

No Headlines